MOS
ZVRA icon

MGO One Seven’s Zevra Therapeutics ZVRA Stock Holding History

MGO One Seven’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,475
Closed -$5K – 476
2020
Q1 		$5K Buy
+1,475
New +$8.16K ﹤0.01% 394

Other funds holding ZVRA

AWA
Arete Wealth Advisors Chicago, Illinois $1.51B AUM 33.02% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $16.1B AUM 40.83% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
ISB
Iowa State Bank Urbandale, Iowa $592M AUM 21.15% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return

MGO One Seven's ZVRA Position: Q2 2020 in Review

MGO One Seven sold out of Zevra Therapeutics (ZVRA) in Q2 2020, closing a stake of 1,475 shares — an estimated $5K sold.

MGO One Seven first reported a position in ZVRA in Q1 2020 and held it in 1 quarter. The position peaked at $5K in Q1 2020. 6 funds tracked by Wall St. Rank hold ZVRA as of Q2 2020.

  • MGO One Seven reported no remaining Zevra Therapeutics position as of Q2 2020 after selling out during the quarter.
  • MGO One Seven sold 1,475 Zevra Therapeutics shares in Q2 2020, an estimated $5K.
  • MGO One Seven first reported a position in Zevra Therapeutics in Q1 2020 and held it in 1 quarter.
  • MGO One Seven's Zevra Therapeutics position peaked at $5K in Q1 2020.
  • 6 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2020.

Based on MGO One Seven's 13F filing for Q2 2020, filed 12 Aug 2020.